TABITHA MATTHEWS: Open Payments
NPI 1447986047 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$283 in 11 payments from 7 companies in 2025. Trend: 2023 $260 · 2024 $476 · 2025 $283
Food & beverage: $283
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $158 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| TAIHO ONCOLOGY, INC. | 1 | $19 |
| GENZYME CORPORATION | 1 | $19 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $17 |
| Incyte Corporation | 1 | $17 |
Products named: EPKINLY, CALQUENCE, ALUNBRIG, LONSURF, SARCLISA, ZYNLONTA, JAKAFI.
Industry payments across MO — which companies pay providers there.
